Mahkam Zanganeh, formerly chief operating officer of Pharmacyclics (now AbbVie Inc), has joined Genoscience Pharma SAS as a member of the board of directors. Based in Marseille, France, Genoscience has a preclinical pipeline of compounds that target cancer stem cells.
Dr Zanganeh will be joined on the board by Robert Duggan and Manmeet Soni, respectively the former Pharmacyclics’ chief executive and chief financial officer, along with Chaim Hurvitz who has worked in management at Teva International Group.
Genoscience announced the appointments on 24 February 2016.
Copyright 2016 Evernow Publishing Ltd